We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$152B
AUM Growth
+$8.01B
Cap. Flow
-$3.16B
Cap. Flow %
-2.08%
Top 10 Hldgs %
10.95%
Holding
6,236
New
317
Increased
2,478
Reduced
1,864
Closed
264

Sector Composition

Rank Sector Weight
1 Financials 14.61%
2 Technology 13.68%
3 Healthcare 11.9%
4 Industrials 11.13%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
3176
DELISTED
Immunogen Inc
IMGN
$99K ﹤0.01%
5,772
-219
-4% -$3.85K
IDLV icon
3177
Invesco S&P International Developed Low Volatility ETF
IDLV
$345M
$98K ﹤0.01%
3,223
-1,377
-30% -$41.2K
NKTR icon
3178
Nektar Therapeutics
NKTR
$2.38B
$98K ﹤0.01%
630
BCIC
3179
BCP Investment Corp
BCIC
$91.3M
$98K ﹤0.01%
1,094
+740
+209% +$70.4K
ORA icon
3180
Ormat Technologies
ORA
$6.02B
$97K ﹤0.01%
3,641
VQT
3181
DELISTED
iPath S&P VEQTOR ETN
VQT
$97K ﹤0.01%
+695
New +$98.4K
SPYG icon
3182
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$53B
$96K ﹤0.01%
4,976
+1,936
+64% +$37K
TCPC icon
3183
BlackRock TCP Capital
TCPC
$283M
$96K ﹤0.01%
5,939
+4,293
+261% +$68.4K
ARNA
3184
DELISTED
Arena Pharmaceuticals Inc
ARNA
$96K ﹤0.01%
1,812
-8
-0.4% -$537
CAD
3185
DELISTED
PIMCO ETF TR PIMCO CDA BD INDEX FD ETF
CAD
$96K ﹤0.01%
1,008
-104
-9% -$9.84K
TRND
3186
DELISTED
ROYAL BK SCOTLAND PLC RBS US LARGE CAP TRENDPILOT ETNS
TRND
$96K ﹤0.01%
2,913
+2,663
+1,065% +$87.1K
CAC icon
3187
Camden National
CAC
$1B
$95K ﹤0.01%
3,497
-15
-0.4% -$386
EWS icon
3188
iShares MSCI Singapore ETF
EWS
$1.05B
$95K ﹤0.01%
3,573
+261
+8% +$6.84K
SHG icon
3189
Shinhan Financial Group
SHG
$33.4B
$95K ﹤0.01%
2,359
+155
+7% +$5.74K
TRS icon
3190
TriMas Corp
TRS
$1.45B
$95K ﹤0.01%
3,218
-31,833
-91% -$948K
EDIV icon
3191
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$94K ﹤0.01%
2,336
+441
+23% +$17.4K
HDG icon
3192
ProShares Hedge Replication ETF
HDG
$22.1M
$94K ﹤0.01%
2,306
+122
+6% +$4.96K
HQL
3193
abrdn Life Sciences Investors
HQL
$586M
$94K ﹤0.01%
4,893
-2,004
-29% -$38.4K
NHS
3194
Neuberger High Yield Strategies Fund Inc
NHS
$252M
$94K ﹤0.01%
7,182
-2,105
-23% -$27.1K
PFL
3195
PIMCO Income Strategy Fund
PFL
$385M
$94K ﹤0.01%
8,138
RPG icon
3196
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
$94K ﹤0.01%
7,395
+1,620
+28% +$19.9K
EON
3197
DELISTED
E.ON AG ADS (REPTG 1/3 ORD SHS)
EON
$94K ﹤0.01%
5,276
+460
+10% +$8.2K
YELL
3198
DELISTED
Yellow Corporation Common Stock
YELL
$94K ﹤0.01%
5,560
+488
+10% +$11.4K
CHT icon
3199
Chunghwa Telecom
CHT
$32.9B
$93K ﹤0.01%
2,845
+189
+7% +$6.03K
SPB icon
3200
Spectrum Brands
SPB
$2.04B
$93K ﹤0.01%
1,420
-60
-4% -$3.67K

Similar funds

Ameriprise's Q3 2013 Portfolio in Review

As of Q3 2013, Ameriprise held 6,236 positions worth $152B, up 5.5% from $144B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Ameriprise's Q3 2013 filing shows 317 new, 2,478 increased, 1,864 reduced and 264 closed positions. Its largest new stake was Wells Fargo & Co.: 830,000 shares worth $19.8M. The largest sale was Edwards Lifesciences, an estimated $333M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Ameriprise's largest Q3 2013 buy was Wells Fargo & Co.: 830,000 shares worth $19.8M.
  • Ameriprise added most to ConocoPhillips in Q3 2013, an estimated $268M increase.
  • Ameriprise's biggest Q3 2013 reduction was Edwards Lifesciences, cutting an estimated $333M.
  • Ameriprise fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $235M.
  • Ameriprise's ten largest holdings make up 11% of its $152B portfolio in Q3 2013.
  • Ameriprise opened 317 new positions and closed 264 in Q3 2013.
  • Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $152B.

Based on Ameriprise's 13F filing for Q3 2013, filed 14 Nov 2013.